Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma

被引:67
作者
Nakamura, S
Akazawa, K
Kinukawa, N
Yao, T
Tsuneyoshi, M
机构
[1] KYUSHU UNIV,FAC MED,DEPT PATHOL 2,FUKUOKA 812,JAPAN
[2] KYUSHU UNIV,FAC MED,DEPT MED INFORMAT,FUKUOKA 812,JAPAN
关键词
gastric lymphoma; mucosa-associated lymphoid tissue; bcl2; p53;
D O I
10.1016/S0046-8177(96)90061-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The immunohistochemical expression of bcl-2 and p53 proteins was evaluated in formalin-fixed, paraffin-embedded surgical specimens from 212 patients with primary gastric lymphoma. bcl-2 protein was found to be expressed in 145 specimens (68%). Among the 179 specimens with B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), bcl-2 positivity decreased significantly as the histological grade advanced; bcl-2 was expressed in 93% of low-grade tumors, 88% of mixed-grade (low-grade with a focal high-grade component) tumors, and 44% of high-grade tumors (Cochran's linear trend test; P < .001). p53 protein expression was detected in 43 of 212 cases (20%). Among the B-cell MALT lymphomas, p53 positivity increased significantly as the histological grade advanced; p53 was expressed in 6% of low-grade tumors, 12% of mixed-grade tumors, and 31% of high-grade tumors (Cochran's linear trend test; P < .001). An inverse correlation was observed between the expression of bcl-2 and p53 in all 212 lymphomas (Gamma = -0.531; P < .05) as well as in all 179 B-cell MALT lymphomas (Gamma = -0.671; P < .01). Although the bcl-2 expression did not correlate with the patient survival, the p53 positive cases showed a significantly poorer prognosis compared with the p53 negative cases (log-rank test; P < .05). These results suggest that the expression of bcl-2 and p53 may, therefore, be associated with the transition from low-grade to high-grade tumors in primary gastric lymphoma. (C) 1996 by W.B. Saunders Company
引用
收藏
页码:225 / 233
页数:9
相关论文
共 44 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]   HETEROGENEITY OF BCL-2 EXPRESSION IN MALT LYMPHOMA [J].
ASHTONKEY, M ;
BIDDOLPH, SC ;
STEIN, H ;
GATTER, KC ;
MASON, DY .
HISTOPATHOLOGY, 1995, 26 (01) :75-78
[3]   CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[4]   P53 IMMUNOHISTOCHEMISTRY - A WORD OF CAUTION [J].
BATTIFORA, H .
HUMAN PATHOLOGY, 1994, 25 (05) :435-437
[5]  
BRAMBILLA E, 1993, AM J PATHOL, V143, P199
[6]   GASTRIC B-CELL MUCOSA ASSOCIATED LYMPHOID-TISSUE LYMPHOMA - A CLINICOPATHOLOGICAL STUDY IN 56 PATIENTS [J].
CASTRILLO, JM ;
MONTALBAN, C ;
OBESO, G ;
PIRIS, MA ;
RIVAS, MC .
GUT, 1992, 33 (10) :1307-1311
[7]  
CESARMAN E, 1993, AM J PATHOL, V143, P845
[9]   SOME METHODS FOR STRENGTHENING THE COMMON X2 TESTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (04) :417-451
[10]   OVEREXPRESSION OF P53 PROTEIN IN ADENOCARCINOMA OF THE PANCREAS [J].
DIGIUSEPPE, JA ;
HRUBAN, RH ;
GOODMAN, SN ;
POLAK, M ;
VANDENBERG, FM ;
ALLISON, DC ;
CAMERON, JL ;
OFFERHAUS, GJA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (06) :684-688